NASDAQ:RGLS

Regulus Therapeutics SEC Filings & 10K Form

$1.33
-0.07 (-5.00 %)
(As of 04/16/2021 11:01 AM ET)
Add
Compare
Today's Range
$1.27
Now: $1.33
$1.35
50-Day Range
$1.15
MA: $1.51
$1.96
52-Week Range
$0.42
Now: $1.33
$2.32
Volume14,579 shs
Average Volume3.04 million shs
Market Capitalization$96.43 million
P/E RatioN/A
Dividend YieldN/A
Beta2.41

SEC Filings

Regulus Therapeutics (NASDAQ:RGLS) SEC Filings

DateFilerForm TypeView
03/17/2021
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
03/16/2021
7:46 PM
Regulus Therapeutics (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:46 PM
Regulus Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:45 PM
Regulus Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:44 PM
MAKOWER JOSHUA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:43 PM
Makhzoumi Mohamad (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:42 PM
Florence Anthony A. Jr. (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:41 PM
Chang Carmen (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:40 PM
Behbahani Ali (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:39 PM
BASKETT FOREST (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
7:38 PM
Growth Equity Opportunities V, LLC (Reporting)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
4:31 PM
Regulus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2021
10:05 AM
Regulus Therapeutics (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G
02/17/2021
4:23 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:23 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
4:01 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
4:00 PM
Drygin Denis (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
3:19 PM
Regulus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/28/2021
3:03 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2021
7:32 PM
BALTIMORE DAVID (Reporting)
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
7:24 PM
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/27/2021
7:16 PM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4/A
01/12/2021
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
12/31/2020
3:03 PM
Regulus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/09/2020
4:13 PM
Point72 Asset Management, L.P. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
12/07/2020
4:14 PM
Regulus Therapeutics (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:13 PM
Regulus Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:12 PM
Regulus Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:12 PM
MAKOWER JOSHUA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:11 PM
Makhzoumi Mohamad (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:10 PM
Florence Anthony A. Jr. (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:10 PM
Chang Carmen (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:09 PM
Behbahani Ali (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:08 PM
BASKETT FOREST (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
4:06 PM
Growth Equity Opportunities V, LLC (Reporting)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:22 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:21 PM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2020
3:18 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
7:40 AM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2020
3:10 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:09 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
3:43 PM
Regulus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:32 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
5:08 AM
Regulus Therapeutics (Filer)
Form 424B5
08/31/2020
3:00 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
7:22 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
7:21 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:30 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2020
3:45 PM
Regulus Therapeutics (Issuer)
Witz Pascale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:44 PM
Regulus Therapeutics (Issuer)
Simeonidis Simos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:43 PM
Regulus Therapeutics (Issuer)
Rosen Hugh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:42 PM
RASTETTER WILLIAM H (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:40 PM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:39 PM
Nunn Jason Raleigh (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:38 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:37 PM
BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
12:49 PM
Regulus Therapeutics (Filer)
Form CT ORDER
05/18/2020
3:28 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:27 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
3:36 PM
Regulus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2020
7:03 PM
Regulus Therapeutics (Issuer)
Sarissa Capital Offshore Master Fund LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
7:01 PM
Regulus Therapeutics (Issuer)
Sarissa Capital Master Fund II LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2020
5:12 AM
Regulus Therapeutics (Filer)
Form DEFA14A
04/29/2020
5:09 AM
Regulus Therapeutics (Filer)
Form DEF 14A
03/27/2020
3:05 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
3:55 PM
Regulus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2020
3:54 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
5:09 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:08 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
4:19 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
02/14/2020
12:51 PM
Altium Capital Management LP (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
02/10/2020
7:07 AM
Regulus Therapeutics (Subject)
Sanofi (Filed by)
Form SC 13G/A
01/29/2020
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
01/24/2020
3:13 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:12 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:11 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
8:01 PM
Regulus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/22/2020
4:27 PM
Regulus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/03/2020
8:53 PM
DENNER ALEXANDER J (Reporting)
Regulus Therapeutics (Issuer)
Sarissa Capital Catapult Fund LLC (Reporting)
Sarissa Capital Hawkeye Fund LP (Reporting)
Sarissa Capital Management LP (Reporting)
Sarissa Capital Offshore Master Fund LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:46 PM
EcoR1 Capital, LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
01/02/2020
8:59 PM
Regulus Therapeutics (Subject)
Sarissa Capital Management LP (Filed by)
Form SC 13D/A
12/31/2019
2:37 PM
Altium Capital Management LP (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
12/26/2019
4:03 PM
Regulus Therapeutics (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:02 PM
Regulus Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:02 PM
Regulus Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:01 PM
MOTT DAVID M (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:01 PM
MAKOWER JOSHUA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:00 PM
Makhzoumi Mohamad (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:00 PM
Florence Anthony A. Jr. (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:59 PM
Chang Carmen (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:59 PM
Behbahani Ali (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:58 PM
BASKETT FOREST (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:57 PM
BARRIS PETER J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:57 PM
Growth Equity Opportunities V, LLC (Reporting)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
7:56 AM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
7:54 AM
Regulus Therapeutics (Issuer)
Witz Pascale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
7:52 AM
RASTETTER WILLIAM H (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
7:50 AM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
7:01 AM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
4:37 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.